Cargando…
Immunological Response to Sars-Cov-2 after Infection and/or Vaccination Among Chronic Myeloid Leukemia Patients - a Prospective Study
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665196/ http://dx.doi.org/10.1182/blood-2022-170363 |
| _version_ | 1784831236768792576 |
|---|---|
| author | Miranda, Marisol Kolhe, Ravindra Bradshaw, Danielle Farmaha, Jaspreet Jones, Kimya Singh, Harmanpreet Vashisht, Ashutosh Sahajpal, Nikhil Cortes, Jorge E. |
| author_facet | Miranda, Marisol Kolhe, Ravindra Bradshaw, Danielle Farmaha, Jaspreet Jones, Kimya Singh, Harmanpreet Vashisht, Ashutosh Sahajpal, Nikhil Cortes, Jorge E. |
| author_sort | Miranda, Marisol |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9665196 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96651962022-11-16 Immunological Response to Sars-Cov-2 after Infection and/or Vaccination Among Chronic Myeloid Leukemia Patients - a Prospective Study Miranda, Marisol Kolhe, Ravindra Bradshaw, Danielle Farmaha, Jaspreet Jones, Kimya Singh, Harmanpreet Vashisht, Ashutosh Sahajpal, Nikhil Cortes, Jorge E. Blood Online Publication Only The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665196/ http://dx.doi.org/10.1182/blood-2022-170363 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Online Publication Only Miranda, Marisol Kolhe, Ravindra Bradshaw, Danielle Farmaha, Jaspreet Jones, Kimya Singh, Harmanpreet Vashisht, Ashutosh Sahajpal, Nikhil Cortes, Jorge E. Immunological Response to Sars-Cov-2 after Infection and/or Vaccination Among Chronic Myeloid Leukemia Patients - a Prospective Study |
| title | Immunological Response to Sars-Cov-2 after Infection and/or Vaccination Among Chronic Myeloid Leukemia Patients - a Prospective Study |
| title_full | Immunological Response to Sars-Cov-2 after Infection and/or Vaccination Among Chronic Myeloid Leukemia Patients - a Prospective Study |
| title_fullStr | Immunological Response to Sars-Cov-2 after Infection and/or Vaccination Among Chronic Myeloid Leukemia Patients - a Prospective Study |
| title_full_unstemmed | Immunological Response to Sars-Cov-2 after Infection and/or Vaccination Among Chronic Myeloid Leukemia Patients - a Prospective Study |
| title_short | Immunological Response to Sars-Cov-2 after Infection and/or Vaccination Among Chronic Myeloid Leukemia Patients - a Prospective Study |
| title_sort | immunological response to sars-cov-2 after infection and/or vaccination among chronic myeloid leukemia patients - a prospective study |
| topic | Online Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665196/ http://dx.doi.org/10.1182/blood-2022-170363 |
| work_keys_str_mv | AT mirandamarisol immunologicalresponsetosarscov2afterinfectionandorvaccinationamongchronicmyeloidleukemiapatientsaprospectivestudy AT kolheravindra immunologicalresponsetosarscov2afterinfectionandorvaccinationamongchronicmyeloidleukemiapatientsaprospectivestudy AT bradshawdanielle immunologicalresponsetosarscov2afterinfectionandorvaccinationamongchronicmyeloidleukemiapatientsaprospectivestudy AT farmahajaspreet immunologicalresponsetosarscov2afterinfectionandorvaccinationamongchronicmyeloidleukemiapatientsaprospectivestudy AT joneskimya immunologicalresponsetosarscov2afterinfectionandorvaccinationamongchronicmyeloidleukemiapatientsaprospectivestudy AT singhharmanpreet immunologicalresponsetosarscov2afterinfectionandorvaccinationamongchronicmyeloidleukemiapatientsaprospectivestudy AT vashishtashutosh immunologicalresponsetosarscov2afterinfectionandorvaccinationamongchronicmyeloidleukemiapatientsaprospectivestudy AT sahajpalnikhil immunologicalresponsetosarscov2afterinfectionandorvaccinationamongchronicmyeloidleukemiapatientsaprospectivestudy AT cortesjorgee immunologicalresponsetosarscov2afterinfectionandorvaccinationamongchronicmyeloidleukemiapatientsaprospectivestudy |